Login to Your Account

Appointments & advancements

Wednesday, January 10, 2018

Harbour Biomed Therapeutics Ltd., of Shanghai, appointed Xiaoxiang Chen executive vice president, head of clinical development and regulatory science. 

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription